Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 789, pseudogene (RNU6-789P) is a human pseudogene locus annotated on chromosome 3 (Ensembl: ENSG00000252914, Entrez Gene ID: 106479915)[1][5][7]. It is homologous to functional U6 small nuclear RNA (snRNA) genes, whose RNA products serve as critical components of the spliceosome, but as a pseudogene, RNU6-789P does not encode a functional RNA or protein product[1][3][5]. Pseudogenes like RNU6-789P are generally considered transcriptionally inactive or non-functional, although recent research suggests some pseudogenes may have regulatory or non-coding roles through various mechanisms, such as non-coding RNA transcription, miRNA sponging, or generation of short peptides[2][4]. There is currently no published evidence that RNU6-789P itself acts as a therapeutic target, has a disease association, or is interacted with by any drugs. Its designation as a pseudogene is supported by multiple genomic databases and by the absence of a functional transcript or protein[1][3][5][7]. Further context: This entry is a pseudogene, meaning it is a genomic DNA sequence similar to a gene but non-functional due to mutations or truncations[2][5]. The related functional U6 small nuclear RNA (not this pseudogene) is involved in pre-mRNA splicing as part of the spliceosome[9]. There are no known therapeutic, biomarker, disease, or mechanistic roles for RNU6-789P specifically. Incorrect as a target: This is not a druggable therapeutic target. It is a genomic pseudogene and does not encode an active enzyme, transporter, receptor, or any canonical drug target class. Summary of assessment: RNU6-789P is a non-functional pseudogene of U6 small nuclear RNA, not a correct therapeutic target, with no established biological or pathological function, and no clinical relevance as a biomarker or drug target based on the current literature and databases[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 789, pseudogene (RNU6-789P).